60 assets in Waldenstrom Macroglobulinemia

Therapeutic assets addressing Waldenstrom Macroglobulinemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
psb202 Waldenstrom Macroglobulinemia	Qilu Puget Sound Biotherapeutics (dba Sound Biologics)	P1	CC (41)
Sgr-1505 Waldenstrom Macroglobulinemia	Schrödinger, Inc.	P1	CC (41)
Synkir-310 Waldenstrom Macroglobulinemia	Verismo Therapeutics	P1	CC (41)
Apg-3288 Waldenstrom Macroglobulinemia	Ascentage Pharma Group Inc.	P1	NR ()

Showing 51 to 60 of 60 assets

PreviousPage 2 of 2Next